![Katja Buhrer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Katja Buhrer worked as a Managing Director at MBS Value Partners, Inc. from 2011 to 2017.
She then served as the COO & VP-Corporate Development & Investor Relations at Kindred Biosciences, Inc. from 2018 to 2021.
In 2022, she became the Chief Strategy Officer at ObsEva SA. Prior to her professional career, Ms. Buhrer completed her undergraduate degree at The University of New South Wales.
Eerdere bekende functies van Katja Buhrer
| Bedrijven | Functie | Einde |
|---|---|---|
| OBSEVA SA | Investor Relations Contact | 02-02-2022 |
| KINDRED BIOSCIENCES, INC. | Operationeel Directeur | 01-12-2021 |
MBS Value Partners, Inc.
 MBS Value Partners, Inc. Investment ManagersFinance Operates as an investor relations and financial communications advisory company | Corporate Officer/Principal | 01-11-2017 |
Opleiding van Katja Buhrer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
32
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for animals | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MBS Value Partners, Inc.
MBS Value Partners, Inc. Investment ManagersFinance Operates as an investor relations and financial communications advisory company | Finance |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
